SG Americas Securities’s Lyell Immunopharma LYEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,594
Closed -$39K 3318
2025
Q1
$39K Sell
3,594
-2,243
-38% -$27.5K ﹤0.01% 3294
2024
Q4
$75K Buy
5,837
+2,959
+103% +$58.7K ﹤0.01% 2816
2024
Q3
$79K Buy
2,878
+1,262
+78% +$37.1K ﹤0.01% 3139
2024
Q2
$47K Sell
1,616
-1,797
-53% -$85.5K ﹤0.01% 2683
2024
Q1
$152K Sell
3,413
-1,548
-31% -$66.3K ﹤0.01% 2192
2023
Q4
$192K Buy
4,961
+2,234
+82% +$80.4K ﹤0.01% 2203
2023
Q3
$80K Buy
+2,727
New +$129K ﹤0.01% 2851
2023
Q2
Sell
-3,398
Closed -$160K 2792
2023
Q1
$160K Buy
3,398
+324
+11% +$17.3K ﹤0.01% 2591
2022
Q4
$213K Buy
3,074
+730
+31% +$72.5K ﹤0.01% 2149
2022
Q3
$344K Sell
2,344
-2,032
-46% -$275K ﹤0.01% 1875
2022
Q2
$571K Buy
4,376
+421
+11% +$43K 0.01% 1853
2022
Q1
$399K Buy
+3,955
New +$479K ﹤0.01% 2023
2021
Q4
Sell
-531
Closed -$157K 3631
2021
Q3
$157K Buy
+531
New +$159K ﹤0.01% 3396

Other funds holding LYEL